CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- 4 Grant or award Director acquired 4,707 shares (grant or award)
- 4 Grant or award Director acquired 4,707 shares (grant or award)
- 4 Grant or award Director acquired 4,707 shares (grant or award)
- 4 Grant or award Director acquired 4,707 shares (grant or award)
- 4 Grant or award Director acquired 4,707 shares (grant or award)
- 4 Open-market sale Director sold 25,000 shares at an average $15.09 ($377,366)
- 4 Grant or award EVP and Chief Medical Officer acquired 42,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes EVP and General Counsel gave up 1,470 shares (to pay taxes)
- 4 Open-market sale Director sold 25,000 shares at $17.17 ($429,250)
- 4 Open-market sale Director sold 25,000 shares at an average $14.81 ($370,224)
- 4 Shares withheld for taxes Director gave up 7,851 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 2,714 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 2,052 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 2,693 shares (to pay taxes)
- 4 Grant or award EVP & Chief Commercial Officer acquired 25,600 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 25,600 shares (grant or award)
- 4 Grant or award Executive Vice President & CFO acquired 32,000 shares (grant or award)
- 4 Grant or award EVP and General Counsel acquired 25,600 shares (grant or award)
- 4 Grant or award President and CEO acquired 90,000 shares (grant or award)
Page 14 of 21 · 415 filings